Clinical trial
Riluzole to Treat Depression in Bipolar Disorder
NCT00054704 · National Institute of Mental Health (NIMH), NIH · Terminated
Key facts
| NCT number | NCT00054704 |
|---|---|
| Title | Riluzole to Treat Depression in Bipolar Disorder |
| Official title | An Investigation of the Antidepressant Efficacy of an Antiglutamatergic Agent in Bipolar Depression |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Riluzole, Placebo |
| Enrollment | 19 |
| Start date | Feb 1, 2003 |
| Primary completion | Dec 1, 2014 |
| Completion | Dec 1, 2014 |
| First posted | Feb 7, 2003 |
| Last update posted | Apr 25, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: